Evaluation of Accelerometer-Based Neuromuscular Monitoring Reliability to Exclude Postoperative Residual Paralysis

计划入组 20 人 · 首次发布于 2012 年 1 月 4 日

Effects of Postoperative Residual Paralysis on Hospital Costs

计划入组 3,000 人 · 首次发布于 2012 年 10 月 31 日

Comparison of AMG and EMG to Avoid Residual Paralysis After General Anesthesia

计划入组 214 人 · 首次发布于 2014 年 4 月 30 日

Blinatumomab(Blincyto)

Rx

Antibody drug conjugate(MabPlex-Agilent ADC Analysis Joint Lab)

allogeneic placenta-derived decidual stromal cell therapy (graft-versus-host-disease)

OFS Credit

United States

CATALYSIS SL

Spain

BOTEC ANALYSIS, LLC

United States

Senzime Secures Major U.S. Hospital Contract and New Patent for TetraGraph Neuromuscular Monitoring System

Advancements in Minimal Residual Disease Assessment Transforming Myeloma Treatment

Pre-Transplant MRD Status Significantly Impacts Survival Outcomes in AML and MDS Patients